Bicknell; Roy
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bicknell; Roy.The latest application filed is for "inhibitors of the interaction between clec14a and multimerin-2 for inhibition of angiogenesis".
- Bicknell; Roy - Birmingham GB
- Bicknell; Roy - Edgbaston Birmingham GB
- Bicknell; Roy - Oxford GB
- Bicknell; Roy - Headington GB
| Patent | Date |
|---|---|
| Inhibitors of the Interaction Between CLEC14A and Multimerin-2 for Inhibition of Angiogenesis App 20210070867 - Bicknell; Roy ; et al. | 2021-03-11 |
| Inhibitors of the interaction between CLEC14A and multimerin-2 for inhibition of angiogenesis Grant 10,808,031 - Bicknell , et al. October 20, 2 | 2020-10-20 |
| Inhibitors App 20190185532 - Bicknell; Roy ; et al. | 2019-06-20 |
| Antibodies And Related Molecules And Uses Thereof App 20190085082 - BICKNELL; Roy ; et al. | 2019-03-21 |
| Chimeric Antigen Receptor App 20190085081 - BICKNELL; Roy ; et al. | 2019-03-21 |
| Inhibitors Of The Interaction Between Clec14a And Multimerin-2 For Inhibition Of Angiogenesis App 20180282418 - Bicknell; Roy ; et al. | 2018-10-04 |
| Conjugated Vaccine App 20160136287 - Toellner; Kai-Michael ; et al. | 2016-05-19 |
| CLEC14A inhibitors Grant 9,255,148 - Bicknell , et al. February 9, 2 | 2016-02-09 |
| Antibodies, polypeptides and uses thereof Grant 8,394,381 - Bicknell , et al. March 12, 2 | 2013-03-12 |
| Clec14a Inhibitors App 20120276000 - Bicknell; Roy ; et al. | 2012-11-01 |
| Imaging, diagnosis and treatment of disease Grant 8,216,584 - Bicknell , et al. July 10, 2 | 2012-07-10 |
| Imaging, diagnosis and treatment of disease Grant 7,740,830 - Bicknell , et al. June 22, 2 | 2010-06-22 |
| Imaging, diagnosis and treatment of disease Grant 7,582,440 - Bicknell , et al. September 1, 2 | 2009-09-01 |
| Imaging, diagnosis and treatment of disease App 20090191572 - Bicknell; Roy ; et al. | 2009-07-30 |
| Imaging, diagnosis and treatment of disease Grant 7,498,034 - Bicknell , et al. March 3, 2 | 2009-03-03 |
| Imaging, diagnosis and treatment of disease App 20080274045 - Bicknell; Roy ; et al. | 2008-11-06 |
| Imaging, diagnosis and treatment of disease App 20080219924 - Bicknell; Roy ; et al. | 2008-09-11 |
| Antibodies, polypeptides and uses thereof App 20080166295 - Bicknell; Roy ; et al. | 2008-07-10 |
| Imaging, diagnosis and treatment of disease App 20080145359 - Bicknell; Roy ; et al. | 2008-06-19 |
| Antibodies, polypeptides and uses thereof App 20080019963 - Bicknell; Roy ; et al. | 2008-01-24 |
| Imaging, diagnosis and treatment of disease App 20070025913 - Bicknell; Roy ; et al. | 2007-02-01 |
| Antibodies, polypeptides and uses thereof App 20060263369 - Bicknell; Roy ; et al. | 2006-11-23 |
| Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis App 20060099143 - Bicknell; Roy ; et al. | 2006-05-11 |
| Therapeutic and diagnostic applications of protein disulphide isomerases App 20050153361 - Sullivan, Dianne C. ; et al. | 2005-07-14 |
| Modulation of cell growth App 20040071707 - Carroll, Veronica A. ; et al. | 2004-04-15 |
| Imaging, diagnosis and treatment of disease App 20040071711 - Bicknell, Roy ; et al. | 2004-04-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 